| Hydroxychloroquine to obtain pregnancy without adverse obstetrical events in primary antiphospholipid syndrome: French phase II multicenter randomized trial, HYDROSAPL |
9 |
| Preterm premature rupture of membranes: CNGOF Guidelines for clinical practice Short - version |
9 |
| Definition, description, clinicopathological features, pathogenesis and natural history of endometriosis: CNGOF-HAS Endometriosis Guidelines |
6 |
| Definition, epidemiology and risk factors of obstetric anal sphincter injuries: CNGOF Perineal Prevention and Protection in Obstetrics Guidelines |
5 |
| Contraception and cancer: CNGOF Contraception Guidelines |
4 |
| Epidemiology, risk factors and child prognosis: CNGOF Preterm Premature Rupture of Membranes Guidelines |
4 |
| Diagnosis and management of intra-uterine infection: CNGOF Preterm Premature Rupture of Membranes Guidelines |
4 |
| Management of tubo-ovarian abscesses and complicated pelvic inflammatory disease: CNGOF and SPILF Pelvic Inflammatory Diseases Guidelines |
4 |
| Pelvic inflammatory diseases: Microbiologic diagnosis - CNGOF and SPILF Pelvic Inflammatory Diseases Guidelines |
3 |
| Postpartum endometritis: CNGOF and SPILF Pelvic Inflammatory Diseases Guidelines |
3 |
| Diagnostic and prognostic value of tumor markers, scores (clinical and biological) algorithms, in front of an ovarian mass suspected of an epithelial ovarian cancer: Article drafted from the French Guidelines in oncology entitled Initial management of patients with epithelial ovarian cancer developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa |
3 |
| Biopathology of ovarian carcinomas early and advanced-stages: Article drafted from the French guidelines in oncology entitled Initial management of patients with epithelial ovarian cancer developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa |
3 |
| Modalities of birth in case of uncomplicated preterm premature rupture of membranes: CNGOF Preterm Premature Rupture of Membranes Guidelines |
3 |
| Management of assisted reproductive technology (ART) in case of endometriosis related infertility: CNGOF-HAS Endometriosis Guidelines |
3 |
| Endometriosis and fertility preservation: CNGOF-HAS Endometriosis Guidelines |
3 |
| Comparison of birth weights of children born after slow frozen embryo replacement versus fresh embryo transfer |
3 |
| Surgical management of endometrioma: Different alternatives in term of pain, fertility and recurrence. CNGOF-HAS Endometriosis Guidelines |
3 |
| Epidemiology and diagnosis strategy: CNGOF-HAS Endometriosis Guidelines |
3 |
| Management of endometriosis: CNGOF-HAS practice guidelines (short version) |
3 |
| Mini-sling versus transobturator sling: Efficiency and morbidity |
2 |
| Obstetrical anal sphincter injuries and vacuum-assisted delivery at term in primiparas |
2 |
| Endometriosis medical treatment: Hormonal treatment for the management of pain and endometriotic lesions recurrence. CNGOF-HAS Endometriosis Guidelines |
2 |
| Conventional analgesics and non-pharmacological multidisciplinary therapeutic treatment in endometriosis: CNGOF-HAS Endometriosis Guidelines |
2 |
| Comparison of obstetric prognosis of attempts of breech delivery: Spontaneous labor versus induced labor |
2 |
| Study of the relations between the pain of childbirth and postpartum, and depressive and traumatic symptoms |
2 |
| Occupational risks during pregnancy: Feedback from occupational medical services |
2 |
| Environment and lifestyle: Impacts on male fertility? |
2 |
| The Rouen Expert center in the diagnosis and multidisciplinary management of endometriosis: A French pilot experiment |
2 |
| Cervical ripening and labor induction: Evaluation of single balloon catheter compared to double balloon catheter and dinoprostone insert |
2 |
| Sentinel node and breast cancer: A state-of-the-art in 2019 |
2 |
| Cesarean after labor induction: Risk factors and prediction score |
2 |
| Evidence-based ways of colorectal anastomotic complications prevention in the setting of digestive deep endometriosis resection: CNGOF-HAS Endometriosis Guidelines |
2 |
| Nerve sparing techniques in deep endometriosis surgery to prevent urinary or digestive functional disorders: Techniques and results: CNGOF-HAS Endometriosis Guidelines |
2 |
| Hormonal contraception and vascular risk: CNGOF Contraception Guidelines |
2 |
| Extragenital endometriosis: Parietal, thoracic, diaphragmatic and nervous lesions. CNGOF-HAS Endometriosis Guidelines |
2 |
| Perineal prevention and protection in obstetrics: CNGOF Clinical Practice Guidelines (short version) |
2 |
| Fetal expulsion: Which interventions for perineal prevention? CNGOF Perineal Prevention and Protection in Obstetrics Guidelines |
2 |
| Diagnosis of rupture of fetal membranes: CNGOF Preterm Premature Rupture of Membranes Guidelines |
2 |
| Antibiotic prophylaxis in preterm premature rupture of membranes: CNGOF preterm premature rupture of membranes guidelines |
2 |
| Antenatal management in case of preterm premature rupture of membranes before fetal viability: CNGOF Preterm Premature Rupture of Membranes Guidelines |
2 |
| Do we need to perform systematic supracervical hysterectomy during laparoscopic sacrocolpopexy? |
2 |
| Anal incontinence and obstetrical anal sphincter injuries, epidemiology and prevention |
2 |
| Follow-up and counselling after pelvic inflammatory disease: CNGOF and SPILF Pelvic Inflammatory Diseases Guidelines |
2 |
| Prevention of postoperative or associated of care pelvic inflammatory diseases: CNGOF and SPILF Pelvic Inflammatory Diseases Guidelines |
2 |
| Impact of the detection of small for gestational age fetuses on the neonatal prognosis |
2 |
| Vaginal hysterectomy in outpatient procedure: Feasibility and satisfaction study |
2 |
| Epithelial ovarian cancer and fertility preservation: Article drafted from the French Guidelines in oncology entitled Initial management of patients with epithelial ovarian cancer developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa |
2 |
| Human Resources for Unplanned Activities in Obstetrics and Gynecology. Consensus statements by the CNGOF, CARO, CNSF, FFRSP, SFAR, SFMP and SFN |
2 |
| Expert centre Cancer du sein et Grossesse (CALG): Concordance between the proposed therapeutics and those finally received |
1 |
| Genetic aspects of male infertility: From bench to clinic |
1 |
